Literature DB >> 6607395

Tripelennamine: enhancement of brain-stimulation reward.

E M Unterwald, L T Kucharski, J E Williams, C Kornetsky.   

Abstract

Thresholds for reinforcing electrical stimulation to the medial forebrain bundle were determined in rats by means of a rate-free psychophysical method. The acute administration of tripelennamine lowered the threshold for rewarding brain stimulation in a dose-dependent manner. These results suggest that the abuse liability of tripelennamine may be related to its ability to sensitize the central neural pathway that mediates reward.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607395     DOI: 10.1016/0024-3205(84)90585-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.

Authors:  Erik B Oleson; Mark J Ferris; Rodrigo A España; Jill Harp; Sara R Jones
Journal:  Eur J Pharmacol       Date:  2012-03-15       Impact factor: 4.432

Review 2.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

3.  Histidine-decarboxylase knockout mice show deficient nonreinforced episodic object memory, improved negatively reinforced water-maze performance, and increased neo- and ventro-striatal dopamine turnover.

Authors:  Ekrem Dere; Maria A De Souza-Silva; Bianca Topic; Richard E Spieler; Helmut L Haas; Joseph P Huston
Journal:  Learn Mem       Date:  2003 Nov-Dec       Impact factor: 2.460

4.  Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats.

Authors:  Jae H Jun; Eric B Thorndike; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

5.  Effects of antihistaminics on naloxone-induced withdrawal in morphine-dependent mice.

Authors:  J C Leza; I Lizasoain; P Lorenzo
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.